China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of a response-guided treatment modality in advanced unresectable and/or solitary distant lymph node metastatic esophageal squamous cell carcinoma: a prospective, multicenter, single-arm, phase II clinical study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133754
Registration Time: 2026/10/07
Type: Interventional study
Primary Sponsor: Shanghai East Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345393
Published by HT Digital Content Services with permission from Health Daily Digest....